Effective therapeutics to counteract the formation of amyloid plaques in Alzheimer's disease and type 2 diabetes are not yet available. Scientists have now come a little bit closer to a solution: They have described a new class of designed macrocyclic peptides that are highly potent inhibitors of amyloid formation.
Source: Care Giving Science Daily
Alzheimer's disease and type 2 diabetes: Hope for inhibitors against amyloid plaques
August 7th, 2018 | Posted by in UncategorizedYou can follow any responses to this entry through the RSS 2.0 You can leave a response, or trackback.
Leave a Reply